WATERTOWN, Mass.--(BUSINESS WIRE)--FORMA Therapeutics (FORMA) announced today that the Company successfully met the first objective under its strategic collaboration agreement with Celgene Corporation, triggering an undisclosed payment from Celgene. In April 2013, FORMA and Celgene entered into a collaboration to discover, develop and commercialize drug candidates to regulate protein homeostasis targets.
Help employers find you! Check out all the jobs and post your resume.
